ACUTE RENAL FAILURE IN PREGNANCY

1
ACUTE RENAL FAILURE IN PREGNANCY
Dr. Mona Shroff, M.D.(OG)
Asst.ProfSMIMER SURAT EMOC Advanced
Trainer (FOGSI,GOI,JHPIEGO EmOC project)
Diploma in O G Ultrasound (Ian Donald)
2
This presentation covers

• BASIC OUTLINE
• Investigations
• MANAGEMENT PRINCIPLES
• Prerenal Vs ATN Vs ACN
• ROLE OF
• Nutrition
• Volume metabolic control
• Diuretics helpful or harmful
  ??
• Dopamine helpful or harmful
  ??
• Dialysis when which ??
• Renal biopsy ??
• Delivery
• Conditions specific to pregnancy

3
DEFINITIONS OF ARF

• The syndrome is characterised by a sudden in
  parenchymal function (UOPlt400ml/d30ml/hr) which
  is usually but not always reversible
• This produces disturbance of water, electrolyte,
  acid base balance and nitrogenous waste products
  blood pressure.

4
Physiological changes in normal gestation

• Kidney weight and size increase
• Dilation of renal calyces, pelves, and ureters
• Urinary stasis
• Glomerular filtration, effective renal plasma
  flow, fractional clearance of urate increase
• Bicarbonate reabsorption threshold decreases

5
Clinical relevance

• Concentrations of serum creatinine, urea N, and
  uric acid of 0.9, 14, and 5.6 mg/dl, normal in
  nonpregnant subjects, are already suspiciously
  high in gravid women.
• Asymptomatic bacteriuria - frank pyelonephritis.
• PP reduction in size should not be mistaken for
  parenchymal loss
• Post renal failure difficult to diagnose
• S.bicarb lower,PCO2 10 mmHg lower

6
Causes

• Bimodal distribution -peaks in the first
  trimester (related to unregulated and/or septic
  abortion,hyperemesis) and the late third
  trimester (related to obstetric complications
  APH,PPH,Preeclampsia, Chorioamnionitis,AFE etc).

7
ATN CORTICAL NECROSIS THOMBOTIC
MICROANGIOPATHIES
8
(No Transcript)
9

• The RIFLE classification (ADQI group) of
  ARF
• Risk (R) - Increase in serum creatinine level X
  1.5 or decrease in GFR by 25, or UO lt0.5 mL/kg/h
  for 6 hours
• Injury (I) - Increase in serum creatinine level X
  2.0 or decrease in GFR by 50, or UO lt0.5 mL/kg/h
  for 12 hours
• Failure (F) - Increase in serum creatinine level
  X 3.0, decrease in GFR by 75, or serum
  creatinine level gt 4 mg/dL UO lt0.3 mL/kg/h for
  24 hours, or anuria for 12 hours
• Loss (L) - Persistent ARF, complete loss of
  kidney function gt4 wk
• End-stage kidney disease (E) - Loss of kidney
  function gt3 months

10
PHASES

• OLIGURIA
• POLYURIA
• RECOVERY

11
Investigations

• BLOOD
• CBC
• Urea,creatinine,uric acid
• Electrolytes
• LFT
• S.proteins
• Coagulation profile
• ABG
• RBS
• Osmolality

• URINE
• sp.gravity
• osmolality
• electrolytes
• proteins
• pigment casts
• c/s
• ECG

12
Management

• Restore or maintain fluid balance
• The maintenance of electrolytes and acid base
  balance
• The maintenance of nutritional support
• Prevention of infection
• Avoid renal toxins (including NSAIDS)
• Instigate renal replacement therapies

13
Prerenal failure

• Adequately replace blood fluid losses,maintain
  BP.
• Control continuing blood loss
• Mannitol (100ml, 25) trial to d/d b/w reversible
  prerenal failure established ATN (provided
  oliguria lt48 hrs UP osmolality gt 1.05)
• If diuresis (gt50ml/hr or doubling) established
  within 3 hrs,maintain NS infusion acc to UOP
  replace electrolytes acc to urinary loss
  estimations.
• If unsuccessful objective is to support the
  functionally anephric pt till kidneys recover.

14
Volume control

• IP/OP charting daily
• State of hydration-wt,hct,protein
• Input Output/24hrs 500ml(nonfebrile)
  
• 200 ml/ deg C of inc. in Tem
• Balance 0.3-0.5kg wt loss/d
• Avoid overhydration Rx diuretics,dialysis
• CVP monitoring (b/w 10-15cm H2O)

15
Diuretics

• Diuretics commonly have been given
  in an attempt to convert the oliguric state to a
  nonoliguric state. However, diuretics have not
  been shown to be beneficial, and they may worsen
  outcomes.
• In the absence of compelling contradictory data
  from a randomized, blinded clinical trial, the
  widespread use of diuretics in critically ill
  patients with acute renal failure should be
  discouraged.
• Useful only in management of fluid-overloaded
  patients

Cantarovich F, Rangoonwala B, Lorenz H, Verho M,
Esnault VL. High-dose furosemide for established
ARF a prospective, randomized, double-blind,
placebo-controlled, multicenter trial. Am J
Kidney Dis 200444402-9. Kellum JA.
Systematic review The use of diuretics and
dopamine in acute renal failure a systematic
review of the evidence. Critical
Care19971(2)539.
16
DOPAMINE

• Dopamine traditionally has been used to promote
  renal perfusion(1-5 mcg/kg/min )
• However, systematic reviews of dopamine
  treatment in critically ill patients and in
  patients with sepsis do not support the use of
  dopamine to prevent renal insufficiency,
  morbidity, or mortality. In the majority of ARF
  studies, dopamine was associated only with an
  increase in urine output.

Kellum JA, Decker MJ. Use of dopamine in acute
renal failure a meta-analysis. Crit Care Med
2001291526-31. Denton MD, Chertow GM, Brady
HR. "Renal-dose" dopamine for the treatment of
acute renal failure scientific rationale,
experimental studies and clinical trials. Kidney
Int 1996504-14.
17
Nutrition

• INTAKE
• 1500 cal (protein free)
• Oral/parenteral
• If vol limitation-50D via central vein
• Essential L-aminoacids K,Mg,PImprove wound
  healing, hasten recovery
• Protein intake of 0.6 g per kg per day

18
Electrolyte acid-base correction

• Hyperkalemia, which can be life-threatening,
  should be treated by
• decreasing the intake of potassium,
• delaying the absorption of potassium,
• exchanging potassium across the gut lumen using
  potassium-binding resins,
• controlling intracellular shifts
• dialysis.
• Acidosis- sodabicarb ,dialysis

19

• Treat coagulopathy with FFP for a prolonged aPTT,
  cryoprecipitate for a fibrinogen level less than
  100 mg/dL, and transfuse platelets for platelet
  counts less than 20,000/mm3
• Timely identification of UTI, proper treatment
  prevention using prophylactic antibiotics

20
Indications for Kidney Replacement Therapy

• Acidosis unresponsive to medical therapy
• Acute, severe, refractory electrolyte changes
  (e.g., hyperkalemia)
• Encephalopathy
• Significant azotemia (blood urea nitrogen level
  gt100 mg per dL 36 mmol per L)
• Significant bleeding
• Uremic pericarditis
• Volume overload

21
Early Prophylactic Dialysis

• Allows more liberal fluid, protein salt intake.
• Prevent hyperkalemic emergencies.
• infectious Cx.
• Improves comfort survival

22
Hemodialysis Vs Peritoneal
dialysis

• Limited usefulness if hypotension
• C/I in actively bleeding pt.
• Controlled anticoagulation reqd
• Volume shifts-careful
• Faster correction

• Can be used in preg/PP pt.
• Easily available
• Simple,inexpensive
• Lower Cx rate
• Minimises rapid metabolic pertubations fluid
  shifts
• Insert cath high direct vision

23
Delivery

• Development of ARF in obs pt is indication of
  delivery in majority cases.
• Deliver if UOPlt20 ml/gt2hrs despite adequate vol
  expansion immediate delivery not expected
• Redistribution of CO better renal perfusion.
• Remove fetus from hostile environment.
• Neonate urea osmotis diuresis -dehydration

24
Renal biopsy

• Potentially v.risky in pregnancy
• Defer until postpartum even if ACN( for
  prognostication).
• Rare indication sudden renal failure before 32
  wks with no obvious cause.

25
Preeclampsia

• A decrease in the GFR occurs secondary to
  intrarenal vasospasm. This may manifest as a
  "prerenal" picture. Acute renal failure (ARF) may
  develop, and acute tubular necrosis (ATN) may
  ensue if this hypoperfusion persists.

26
Pre-eclampsia ManagementRenal problems

• Hyperuricaemia and proteinuria are NOT
  indications for delivery per se
• Consider delivery for progressive renal
  impairment (creatinine gt0.09 mmol/L)
• Care with fluids (pulmonary oedema can kill!)
• Kidney Function is Criticalfor Drug Elimination

27
Pre-eclampsiaInvasive monitoring

• CVP monitoring may NOT be helpful!
• poor correlation between CVP and PCWP
• PA catheters have risks!
• rare indications
• pulmonary oedema resistant to diuretics
• oliguric renal failure despite volume expansion

28
Idiopathic postpartum renal failure

• Associated primarily with microangiopathic
  processes
• Postpartum hemolytic-uremic syndrome.
• These were often irreversible and were
  associated with substantial mortality.
• Now improved outcome with plasma
  exchange,dialysis,prostacyclin infusion,
  correcting coagulopathy

29
ACUTE FATTY LIVER OF PREGNANCY

• Associated with acute renal failure in up to
  60 percent of cases.
• The diagnosis should be suspected in a woman
  with preeclampsia who has jaundice,hypoglycemia,
  hypofibrinogenemia, and a prolonged PTT in the
  absence of abruptio placentae.

30
KEY RECOMMENDATIONS FOR PRACTICE

• Identify prevent at prerenal phase as early as
  possible
• Dopamine should not be used to prevent
• acute renal failure. (Evidence level A)
• Diuretics should not be used to treat oliguria in
  patients with acute renal failure unless volume
  overload (Evidence level B)
• Early prophylactic dialysis should be strongly
  considered.
• The maintenance of electrolytes,acid base balance
  nutritional support plays vital role.

31

• THANK YOU